Chapter 1. Preface

1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology

Chapter 2. Executive Summary

2.1 Global Mitral Valve Disease Market, (2025 - 2034) (USD Billion)
2.2 Global Mitral Valve Disease Market: Snapshot

Chapter 3. Global Mitral Valve Disease Market - Industry Analysis

3.1 Mitral Valve Disease Market: Market Dynamics
3.2 Market Drivers
3.2.1 The Mitral Valve Disease Market is primarily driven by the surging geriatric population highly susceptible to degenerative mitral regurgitation, the rapid shift toward minimally invasive transcatheter procedures (TMVR/TEER) that offer lower surgical risk, and breakthroughs in 3D imaging and AI-assisted diagnostics that enable earlier and more precise clinical intervention.
3.3 Market Restraints
3.3.1 Opportunities in the Mitral Valve Disease Market are primarily driven by the integration of AI and 3D echocardiography for hyper-precise procedural planning, the revolutionary potential of regenerative medicine and tissue-engineered bioprosthetic valves, and the rise of personalized structural heart care enabled by 3D-printed patient-specific anatomical models.
3.4 Market Opportunities
3.4.1 Opportunities in the Mitral Valve Disease Market are primarily driven by the integration of AI and 3D printing for patient-specific procedural planning, the rapid expansion of specialized cardiac centers in high-growth regions like Asia-Pacific, and the transformative potential of regenerative medicine and stem cell therapies that aim to provide long-term biological repair of heart valves.
3.5 Market Challenges
3.5.1 The challenges in the Mitral Valve Disease Market are primarily driven by the clinical complexity of managing multi-morbid patients (e.g., those with atrial fibrillation and renal failure), supply chain vulnerabilities for critical bioprosthetic materials like Nitinol and bovine tissue, and the stagnant reimbursement landscape that struggles to keep pace with the high costs of transcatheter innovation.
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Treatment Type
3.7.2 Market attractiveness analysis By Indication
3.7.3 Market attractiveness analysis By End-User

Chapter 4. Global Mitral Valve Disease Market- Competitive Landscape

4.1 Company market share analysis
4.1.1 Global Mitral Valve Disease Market: company market share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis

Chapter 5. Global Mitral Valve Disease Market - Treatment Type Analysis

5.1 Global Mitral Valve Disease Market Overview: Treatment Type
5.1.1 Global Mitral Valve Disease Market share, By Treatment Type, 2024 and 2034
5.2 Mitral Valve Repair
5.2.1 Global Mitral Valve Disease Market by Mitral Valve Repair, 2025 - 2034 (USD Billion)
5.3 Mitral Valve Replacement
5.3.1 Global Mitral Valve Disease Market by Mitral Valve Replacement, 2025 - 2034 (USD Billion)
5.4 Cardiac Resynchronization Therapy
5.4.1 Global Mitral Valve Disease Market by Cardiac Resynchronization Therapy, 2025 - 2034 (USD Billion)
5.5 Mitral Valve Therapeutics
5.5.1 Global Mitral Valve Disease Market by Mitral Valve Therapeutics, 2025 - 2034 (USD Billion)
5.6 and Others
5.6.1 Global Mitral Valve Disease Market by and Others, 2025 - 2034 (USD Billion)

Chapter 6. Global Mitral Valve Disease Market - Indication Analysis

6.1 Global Mitral Valve Disease Market Overview: Indication
6.1.1 Global Mitral Valve Disease Market share, By Indication, 2024 and 2034
6.2 Mitral Valve Stenosis
6.2.1 Global Mitral Valve Disease Market by Mitral Valve Stenosis, 2025 - 2034 (USD Billion)
6.3 Mitral Valve Prolapse
6.3.1 Global Mitral Valve Disease Market by Mitral Valve Prolapse, 2025 - 2034 (USD Billion)
6.4 Mitral Valve Regurgitation
6.4.1 Global Mitral Valve Disease Market by Mitral Valve Regurgitation, 2025 - 2034 (USD Billion)
6.5 and Others
6.5.1 Global Mitral Valve Disease Market by and Others, 2025 - 2034 (USD Billion)

Chapter 7. Global Mitral Valve Disease Market - End-User Analysis

7.1 Global Mitral Valve Disease Market Overview: End-User
7.1.1 Global Mitral Valve Disease Market share, By End-User, 2024 and 2034
7.2 Hospitals
7.2.1 Global Mitral Valve Disease Market by Hospitals, 2025 - 2034 (USD Billion)
7.3 Ambulatory Surgical Centers
7.3.1 Global Mitral Valve Disease Market by Ambulatory Surgical Centers, 2025 - 2034 (USD Billion)
7.4 Specialty Clinics
7.4.1 Global Mitral Valve Disease Market by Specialty Clinics, 2025 - 2034 (USD Billion)
7.5 Cardiac Rehabilitation Centers
7.5.1 Global Mitral Valve Disease Market by Cardiac Rehabilitation Centers, 2025 - 2034 (USD Billion)
7.6 and Others
7.6.1 Global Mitral Valve Disease Market by and Others, 2025 - 2034 (USD Billion)

Chapter 8. Mitral Valve Disease Market - Regional Analysis

8.1 Global Mitral Valve Disease Market Regional Overview
8.2 Global Mitral Valve Disease Market Share, by Region, 2024 & 2034 (USD Billion)
8.3 North America
8.3.1 North America Mitral Valve Disease Market, 2025 - 2034 (USD Billion)
8.3.1.1 North America Mitral Valve Disease Market, by Country, 2025 - 2034 (USD Billion)
8.3.2 North America Mitral Valve Disease Market, by Treatment Type, 2025 - 2034
8.3.2.1 North America Mitral Valve Disease Market, by Treatment Type, 2025 - 2034 (USD Billion)
8.3.3 North America Mitral Valve Disease Market, by Indication, 2025 - 2034
8.3.3.1 North America Mitral Valve Disease Market, by Indication, 2025 - 2034 (USD Billion)
8.3.4 North America Mitral Valve Disease Market, by End-User, 2025 - 2034
8.3.4.1 North America Mitral Valve Disease Market, by End-User, 2025 - 2034 (USD Billion)
8.4 Europe
8.4.1 Europe Mitral Valve Disease Market, 2025 - 2034 (USD Billion)
8.4.1.1 Europe Mitral Valve Disease Market, by Country, 2025 - 2034 (USD Billion)
8.4.2 Europe Mitral Valve Disease Market, by Treatment Type, 2025 - 2034
8.4.2.1 Europe Mitral Valve Disease Market, by Treatment Type, 2025 - 2034 (USD Billion)
8.4.3 Europe Mitral Valve Disease Market, by Indication, 2025 - 2034
8.4.3.1 Europe Mitral Valve Disease Market, by Indication, 2025 - 2034 (USD Billion)
8.4.4 Europe Mitral Valve Disease Market, by End-User, 2025 - 2034
8.4.4.1 Europe Mitral Valve Disease Market, by End-User, 2025 - 2034 (USD Billion)
8.5 Asia Pacific
8.5.1 Asia Pacific Mitral Valve Disease Market, 2025 - 2034 (USD Billion)
8.5.1.1 Asia Pacific Mitral Valve Disease Market, by Country, 2025 - 2034 (USD Billion)
8.5.2 Asia Pacific Mitral Valve Disease Market, by Treatment Type, 2025 - 2034
8.5.2.1 Asia Pacific Mitral Valve Disease Market, by Treatment Type, 2025 - 2034 (USD Billion)
8.5.3 Asia Pacific Mitral Valve Disease Market, by Indication, 2025 - 2034
8.5.3.1 Asia Pacific Mitral Valve Disease Market, by Indication, 2025 - 2034 (USD Billion)
8.5.4 Asia Pacific Mitral Valve Disease Market, by End-User, 2025 - 2034
8.5.4.1 Asia Pacific Mitral Valve Disease Market, by End-User, 2025 - 2034 (USD Billion)
8.6 Latin America
8.6.1 Latin America Mitral Valve Disease Market, 2025 - 2034 (USD Billion)
8.6.1.1 Latin America Mitral Valve Disease Market, by Country, 2025 - 2034 (USD Billion)
8.6.2 Latin America Mitral Valve Disease Market, by Treatment Type, 2025 - 2034
8.6.2.1 Latin America Mitral Valve Disease Market, by Treatment Type, 2025 - 2034 (USD Billion)
8.6.3 Latin America Mitral Valve Disease Market, by Indication, 2025 - 2034
8.6.3.1 Latin America Mitral Valve Disease Market, by Indication, 2025 - 2034 (USD Billion)
8.6.4 Latin America Mitral Valve Disease Market, by End-User, 2025 - 2034
8.6.4.1 Latin America Mitral Valve Disease Market, by End-User, 2025 - 2034 (USD Billion)
8.7 The Middle-East and Africa
8.7.1 The Middle-East and Africa Mitral Valve Disease Market, 2025 - 2034 (USD Billion)
8.7.1.1 The Middle-East and Africa Mitral Valve Disease Market, by Country, 2025 - 2034 (USD Billion)
8.7.2 The Middle-East and Africa Mitral Valve Disease Market, by Treatment Type, 2025 - 2034
8.7.2.1 The Middle-East and Africa Mitral Valve Disease Market, by Treatment Type, 2025 - 2034 (USD Billion)
8.7.3 The Middle-East and Africa Mitral Valve Disease Market, by Indication, 2025 - 2034
8.7.3.1 The Middle-East and Africa Mitral Valve Disease Market, by Indication, 2025 - 2034 (USD Billion)
8.7.4 The Middle-East and Africa Mitral Valve Disease Market, by End-User, 2025 - 2034
8.7.4.1 The Middle-East and Africa Mitral Valve Disease Market, by End-User, 2025 - 2034 (USD Billion)

Chapter 9. Company Profiles

9.1 Edwards Lifesciences Corporation
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Medtronic Plc
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Abbott Laboratories
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Boston Scientific Corporation
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Corcym UK Limited
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 and Others.
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments

Frequently Asked Questions

The mitral valve disease market encompasses treatments, devices, and therapeutics for conditions affecting the mitral valve, including regurgitation, stenosis, and prolapse.

Key factors include aging populations, technological advancements in minimally invasive procedures, and rising cardiovascular disease prevalence.

The market is projected to grow from USD 3.28 billion in 2026 to USD 7.5 billion by 2035.

The CAGR is expected to be 9.2%.

North America will contribute notably, with the largest share due to advanced infrastructure in the US.

Major players include Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, and Corcym UK Limited.

The report provides analysis of market size, trends, segments, regional insights, key players, and forecasts from 2026 to 2035.

Stages include raw material sourcing, device manufacturing, clinical trials, regulatory approval, distribution, and patient treatment.

Trends are evolving toward minimally invasive and personalized treatments, with preferences for durable, low-risk options.

Stringent device approvals and sustainability demands for biocompatible materials influence development and adoption.